11.11.2009 • News

Linde Sees Further Recovery In H2

Linde says H1 operating margin increases to 20.2 % despite ­restructuring costs. The company said H1 improved operating cash flow: €841 million (2008: €816 million). Group sales are down 12.5 % to €5.476 billion. Second-quarter sales of €2.781 billion versus €3.339 billion, and second-quarter operating profit €566 million versus €656 million. The company said further recovery in business trends is expected compared with the first half of the year; however, 2008 record level is no longer attainable.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.